Exelixis Historical Balance Sheet

EXEL Stock

USD 36.96 0.22 0.59%

Trend analysis of Exelixis balance sheet accounts such as Common Stock Shares Outstanding of 183.9 M or Liabilities And Stockholders Equity of 3.1 B provides information on Exelixis' total assets, liabilities, and equity, which is the actual value of Exelixis to its prevalent stockholders. By breaking down trends over time using Exelixis balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Exelixis latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Exelixis is a good buy for the upcoming year.

Exelixis Inventory

23.51 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

About Exelixis Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Exelixis at a specified time, usually calculated after every quarter, six months, or one year. Exelixis Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Exelixis and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Exelixis currently owns. An asset can also be divided into two categories, current and non-current.

Exelixis Balance Sheet Chart

At this time, Exelixis' Property Plant And Equipment Net is quite stable compared to the past year. Accounts Payable is expected to rise to about 40.1 M this year, although the value of Common Stock Shares Outstanding will most likely fall to about 183.9 M.

Total Assets Common Stock Shares Outstanding Other Stockholder Equity Short Long Term Debt Total

Add Fundamental

Total Assets

Total assets refers to the total amount of Exelixis assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Exelixis books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most accounts from Exelixis' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Exelixis current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.At this time, Exelixis' Property Plant And Equipment Net is quite stable compared to the past year. Accounts Payable is expected to rise to about 40.1 M this year, although the value of Common Stock Shares Outstanding will most likely fall to about 183.9 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	190.2M	189.9M	190.8M	180.8M
Other Stockholder Equity	2.5B	2.4B	2.3B	1.4B

Short Long Term Debt Total Other Stockholder Equity

Exelixis balance sheet Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Common Stock Shares Outstanding	Other Stockholder Equity	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Other Assets	Long Term Debt
Total Assets		0.99	0.75	0.63	0.64	-0.33	0.9	0.87	0.88	-0.61	0.95	0.7	0.96	0.78	0.95	0.95	0.97	-0.12	0.9	0.44	0.97	-0.34	-0.33	-0.01	0.95	-0.57
Total Stockholder Equity	0.99		0.8	0.63	0.65	-0.42	0.84	0.8	0.82	-0.7	0.91	0.74	0.93	0.71	0.96	0.95	0.97	-0.26	0.86	0.31	0.97	-0.4	-0.27	-0.07	0.96	-0.62
Retained Earnings	0.75	0.8		0.12	0.29	-0.54	0.67	0.52	0.69	-0.56	0.71	0.46	0.74	0.6	0.69	0.73	0.73	-0.47	0.6	-0.02	0.71	-0.59	0.3	-0.32	0.77	-0.59
Common Stock Shares Outstanding	0.63	0.63	0.12		0.79	-0.2	0.39	0.51	0.4	-0.63	0.5	0.72	0.51	0.23	0.7	0.63	0.63	-0.06	0.54	0.4	0.69	-0.04	-0.67	0.24	0.56	-0.42
Other Stockholder Equity	0.64	0.65	0.29	0.79		-0.02	0.46	0.37	0.46	-0.49	0.53	0.66	0.57	0.3	0.65	0.6	0.58	0.05	0.39	0.35	0.65	-0.17	-0.59	-0.22	0.6	-0.11
Short Long Term Debt Total	-0.33	-0.42	-0.54	-0.2	-0.02		-0.13	-0.22	-0.15	0.68	-0.22	-0.31	-0.22	-0.08	-0.4	-0.42	-0.41	0.76	-0.27	0.36	-0.4	0.79	-0.27	-0.19	-0.34	0.83
Other Current Liab	0.9	0.84	0.67	0.39	0.46	-0.13		0.93	0.88	-0.37	0.95	0.53	0.89	0.89	0.81	0.86	0.85	0.11	0.91	0.62	0.84	-0.23	-0.25	0.02	0.82	-0.39
Total Current Liabilities	0.87	0.8	0.52	0.51	0.37	-0.22	0.93		0.84	-0.38	0.9	0.51	0.85	0.84	0.8	0.85	0.84	0.09	0.95	0.66	0.82	-0.18	-0.37	0.27	0.78	-0.52
Property Plant And Equipment Net	0.88	0.82	0.69	0.4	0.46	-0.15	0.88	0.84		-0.3	0.92	0.39	0.96	0.91	0.7	0.79	0.77	0.14	0.81	0.59	0.73	-0.25	-0.17	0.09	0.86	-0.46
Net Debt	-0.61	-0.7	-0.56	-0.63	-0.49	0.68	-0.37	-0.38	-0.3		-0.44	-0.86	-0.42	-0.11	-0.76	-0.71	-0.65	0.66	-0.45	0.15	-0.75	0.4	0.06	-0.06	-0.56	0.74
Accounts Payable	0.95	0.91	0.71	0.5	0.53	-0.22	0.95	0.9	0.92	-0.44		0.53	0.95	0.9	0.85	0.91	0.91	0.03	0.91	0.53	0.88	-0.26	-0.25	0.06	0.91	-0.5
Cash	0.7	0.74	0.46	0.72	0.66	-0.31	0.53	0.51	0.39	-0.86	0.53		0.51	0.18	0.84	0.72	0.69	-0.3	0.58	0.21	0.82	-0.22	-0.35	-0.07	0.59	-0.43
Non Current Assets Total	0.96	0.93	0.74	0.51	0.57	-0.22	0.89	0.85	0.96	-0.42	0.95	0.51		0.88	0.83	0.88	0.89	0.02	0.86	0.51	0.85	-0.31	-0.28	-0.01	0.94	-0.48
Non Currrent Assets Other	0.78	0.71	0.6	0.23	0.3	-0.08	0.89	0.84	0.91	-0.11	0.9	0.18	0.88		0.59	0.75	0.71	0.22	0.78	0.59	0.64	-0.18	-0.16	0.12	0.79	-0.36
Cash And Short Term Investments	0.95	0.96	0.69	0.7	0.65	-0.4	0.81	0.8	0.7	-0.76	0.85	0.84	0.83	0.59		0.93	0.97	-0.26	0.87	0.33	1.0	-0.35	-0.36	-0.02	0.87	-0.59
Net Receivables	0.95	0.95	0.73	0.63	0.6	-0.42	0.86	0.85	0.79	-0.71	0.91	0.72	0.88	0.75	0.93		0.93	-0.25	0.84	0.33	0.95	-0.32	-0.28	0.05	0.94	-0.66
Short Term Investments	0.97	0.97	0.73	0.63	0.58	-0.41	0.85	0.84	0.77	-0.65	0.91	0.69	0.89	0.71	0.97	0.93		-0.22	0.92	0.35	0.98	-0.38	-0.33	0.01	0.91	-0.6
Non Current Liabilities Total	-0.12	-0.26	-0.47	-0.06	0.05	0.76	0.11	0.09	0.14	0.66	0.03	-0.3	0.02	0.22	-0.26	-0.25	-0.22		0.0	0.74	-0.25	0.43	-0.43	0.22	-0.2	0.64
Other Current Assets	0.9	0.86	0.6	0.54	0.39	-0.27	0.91	0.95	0.81	-0.45	0.91	0.58	0.86	0.78	0.87	0.84	0.92	0.0		0.58	0.88	-0.25	-0.33	0.18	0.81	-0.54
Total Liab	0.44	0.31	-0.02	0.4	0.35	0.36	0.62	0.66	0.59	0.15	0.53	0.21	0.51	0.59	0.33	0.33	0.35	0.74	0.58		0.34	0.16	-0.54	0.32	0.31	0.1
Total Current Assets	0.97	0.97	0.71	0.69	0.65	-0.4	0.84	0.82	0.73	-0.75	0.88	0.82	0.85	0.64	1.0	0.95	0.98	-0.25	0.88	0.34		-0.35	-0.35	-0.01	0.89	-0.6
Short Term Debt	-0.34	-0.4	-0.59	-0.04	-0.17	0.79	-0.23	-0.18	-0.25	0.4	-0.26	-0.22	-0.31	-0.18	-0.35	-0.32	-0.38	0.43	-0.25	0.16	-0.35		-0.15	0.13	-0.34	0.43
Common Stock	-0.33	-0.27	0.3	-0.67	-0.59	-0.27	-0.25	-0.37	-0.17	0.06	-0.25	-0.35	-0.28	-0.16	-0.36	-0.28	-0.33	-0.43	-0.33	-0.54	-0.35	-0.15		-0.16	-0.26	-0.18
Other Liab	-0.01	-0.07	-0.32	0.24	-0.22	-0.19	0.02	0.27	0.09	-0.06	0.06	-0.07	-0.01	0.12	-0.02	0.05	0.01	0.22	0.18	0.32	-0.01	0.13	-0.16		-0.09	-0.4
Other Assets	0.95	0.96	0.77	0.56	0.6	-0.34	0.82	0.78	0.86	-0.56	0.91	0.59	0.94	0.79	0.87	0.94	0.91	-0.2	0.81	0.31	0.89	-0.34	-0.26	-0.09		-0.57
Long Term Debt	-0.57	-0.62	-0.59	-0.42	-0.11	0.83	-0.39	-0.52	-0.46	0.74	-0.5	-0.43	-0.48	-0.36	-0.59	-0.66	-0.6	0.64	-0.54	0.1	-0.6	0.43	-0.18	-0.4	-0.57

Click cells to compare fundamentals

Exelixis Account Relationship Matchups

Exelixis balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.1B	2.6B	3.1B	2.9B	2.9B	3.1B
Total Stockholder Equity	1.9B	2.2B	2.5B	2.3B	2.2B	2.4B
Retained Earnings	(447.6M)	(216.5M)	(34.2M)	(173.4M)	(98.6M)	(103.6M)
Common Stock Shares Outstanding	318.0M	322.4M	324.6M	321.5M	296.1M	183.9M
Liabilities And Stockholders Equity	2.1B	2.6B	3.1B	2.9B	2.9B	3.1B
Other Stockholder Equity	2.3B	2.4B	2.5B	2.4B	2.3B	1.4B
Short Long Term Debt Total	49.1M	51.3M	190.2M	189.9M	190.8M	180.8M
Other Current Liab	179.2M	313.3M	284.2M	360.5M	365.6M	383.9M
Total Current Liabilities	204.7M	337.6M	324.4M	394.3M	403.8M	424.0M
Property Plant And Equipment Net	67.4M	104.0M	401.2M	470.9M	359.1M	377.1M
Net Debt	(270.1M)	(595.9M)	(311.0M)	(73.1M)	(26.6M)	(27.9M)
Accounts Payable	23.6M	24.3M	32.7M	33.8M	38.2M	40.1M
Cash	319.2M	647.2M	501.2M	263.0M	217.4M	192.8M
Non Current Assets Total	691.9M	781.5M	1.5B	1.6B	1.5B	1.6B
Non Currrent Assets Other	71.9M	131.0M	290.6M	637.3M	732.9M	769.5M
Cash And Short Term Investments	1.2B	1.5B	1.3B	995.3M	1.1B	1.2B
Net Receivables	160.9M	282.7M	214.8M	237.4M	265.4M	278.7M
Short Term Investments	887.3M	819.9M	807.3M	732.3M	893.9M	938.6M
Non Current Liabilities Total	53.6M	68.0M	258.7M	284.2M	299.7M	217.6M
Other Current Assets	57.0M	57.5M	62.2M	67.9M	68.5M	71.9M
Total Liab	258.2M	405.6M	583.1M	678.4M	703.5M	385.8M
Total Current Assets	1.4B	1.8B	1.6B	1.3B	1.5B	1.5B
Accumulated Other Comprehensive Income	4.5M	(758K)	(14.5M)	(3.8M)	(1.3M)	(1.4M)
Short Term Debt	3.0M	8.7M	17.7M	25.7M	29.6M	50.4M
Common Stock	312K	319K	324K	303K	282K	267.9K
Other Liab	8.9M	4.5M	16.8M	68.5M	78.8M	83.4M
Other Assets	185.3M	187.1M	197.5M	286.9M	329.9M	346.4M
Common Stock Total Equity	300K	305K	312K	324K	372.6K	391.2K
Inventory	21.0M	27.5M	33.3M	17.3M	22.4M	23.5M
Property Plant And Equipment Gross	67.4M	144.9M	462.1M	551.2M	459.8M	482.8M
Property Plant Equipment	48.9M	67.4M	149.2M	110.6M	127.2M	133.6M
Current Deferred Revenue	1.8M	8.7M	6.6M	5.4M	4.9M	4.6M
Net Tangible Assets	1.6B	1.8B	2.0B	2.4B	2.8B	2.9B
Retained Earnings Total Equity	(880.4M)	(559.4M)	(447.6M)	(34.2M)	(39.4M)	(41.3M)
Capital Surpluse	2.2B	2.2B	2.3B	2.5B	2.9B	2.1B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:

How To Invest In Exelixis

Details

Is Exelixis Stock a good investment?

Details

What is Exelixis' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.754

Earnings Share

1.75

Revenue Per Share

7.478

Quarterly Revenue Growth

0.182

Return On Assets

0.1464

The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Exelixis Historical Balance Sheet

Exelixis Inventory

23.51 Million

About Exelixis Balance Sheet Analysis

Exelixis Balance Sheet Chart

Total Assets

Common Stock Shares Outstanding

Exelixis balance sheet Correlations

Exelixis Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Exelixis balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.98	Short Term Investments
Short Term Investments	+ 0.97	Total Assets
Total Current Assets	+ 0.97	Total Assets
Short Term Investments	+ 0.97	Total Stockholder Equity

Cash	- 0.86	Net Debt
Cash And Short Term Investments	- 0.76	Net Debt
Total Current Assets	- 0.75	Net Debt
Net Receivables	- 0.71	Net Debt
Net Debt	- 0.7	Total Stockholder Equity
Common Stock	- 0.67	Common Stock Shares Outstanding